These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4638209)

  • 1. The macro- and microdistribution and polymorphic electroencephalographic effects of 9 -tetrahydrocannabinol in the rat.
    Shannon ME; Fried PA
    Psychopharmacologia; 1972; 27(2):141-56. PubMed ID: 4638209
    [No Abstract]   [Full Text] [Related]  

  • 2. Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice.
    Gill EW; Jones G; Lawrence DK
    Biochem Pharmacol; 1973 Jan; 22(2):175-84. PubMed ID: 4763251
    [No Abstract]   [Full Text] [Related]  

  • 3. Delta 9-tetrahydrocannabinol: electroencephalographic changes and autonomic responses in the rabbit.
    Fujimori M; Trusty DM; Himwich HE
    Life Sci; 1973 Jun; 12(12):553-63. PubMed ID: 4752482
    [No Abstract]   [Full Text] [Related]  

  • 4. Delta9-tetrahydrocannabinol: subcortical spike bursts and motor manifestations in a Fischer rat treated orally for 109 days.
    Stadnicki SW; Schaeppi U; Rosenkrantz H; Braude MC
    Life Sci; 1974 Feb; 14(3):463-72. PubMed ID: 4823985
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of delta-9-tetrahydrocannabinol in the organs of a suspected case of cannabis poisoning.
    Tewari SN; Sharma JD
    Toxicol Lett; 1980 Mar; 5(3-4):279-81. PubMed ID: 6258270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induction of lymphoblastic transformation with delta-9-tetrahydrocannabinol in mice].
    Nagel MD; Zagury D; Nahas G
    C R Acad Hebd Seances Acad Sci D; 1973 Feb; 276(6):1089-91. PubMed ID: 4196778
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative pharmacological potency in mice of optical isomers of delta 1-tetrahydrocannabinol.
    Jones G; Pertwee RG; Gill EW; Paton WD; Nilsson IM; Widman M; Agurell S
    Biochem Pharmacol; 1974 Jan; 23(2):439-46. PubMed ID: 4813356
    [No Abstract]   [Full Text] [Related]  

  • 8. Delta 9-THC: selective impairment of corticosterone uptake by limbic structures of the rat.
    Drew WG; Slagel DE
    Neuropharmacology; 1973 Sep; 12(9):909-14. PubMed ID: 4746452
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of delta-9-tetrahydrocannabinol on gangliosides and sialoglycoproteins in subcellular fractions of rat brain.
    Sarkar C; Ghosh JJ
    J Neurochem; 1976 Apr; 26(4):721-3. PubMed ID: 965964
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of delta-9-tetrahydrocannabinol on cerebral circulation and function.
    Beaconsfield P; Carpi A; Cartoni C; De Basso P; Rainsbury R
    Lancet; 1972 Nov; 2(7787):1146. PubMed ID: 4117226
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of delta-9-tetrahydrocannabinol administration on the lipid constituents of rat brain subcellular fractions.
    Sarkar C; Ghosh JJ
    J Neurochem; 1975 Feb; 24(2):381-5. PubMed ID: 1113115
    [No Abstract]   [Full Text] [Related]  

  • 12. Delta-9-tetrahydrocannabinol action and neuronal membrane-bound enzymes.
    Ghosh JJ; Poddar MK; Nag D; Biswas B
    Prog Brain Res; 1975; 42():375. PubMed ID: 735
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of an extract of cannabis and of some cannabinols on catecholamine metabolism in rat brain and heart.
    Maître L; Staehelin M; Bein HJ
    Agents Actions; 1970 Mar; 1(3):136-43. PubMed ID: 5520363
    [No Abstract]   [Full Text] [Related]  

  • 14. Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with 3 H- 9 -tetrahydrocannabinol.
    Dewey WL; McMillan DE; Harris LS; Turk RF
    Biochem Pharmacol; 1973 Feb; 22(3):399-405. PubMed ID: 4687135
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of chronic treatment with delta 9-tetrahydrocannabinol on catecholamine synthesis in the rat.
    Mazurkiewicz-Kwilecki IM; Filczewski M
    Psychopharmacologia; 1973 Oct; 33(1):71-9. PubMed ID: 4797647
    [No Abstract]   [Full Text] [Related]  

  • 16. Electroencephalographic study of the effects of tetrahydrocannabinols on sleep in the rat.
    Moreton JE; Davis WM
    Neuropharmacology; 1973 Sep; 12(9):897-907. PubMed ID: 4355678
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of orally administered 9 -tetrahydrocannabinol.
    Perez-Reyes M; Lipton MA; Timmons MC; Wall ME; Brine DR; Davis KH
    Clin Pharmacol Ther; 1973; 14(1):48-55. PubMed ID: 4683071
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the effects of 1 -tetrahydrocannabinol ( 1 -THC) and DDT on the hepatic microsomal metabolism of 1 -THC and other compounds in the rat.
    Kupfer D; Levin E; Burstein SH
    Chem Biol Interact; 1973 Jan; 6(1):59-66. PubMed ID: 4689910
    [No Abstract]   [Full Text] [Related]  

  • 19. Tetrahydrocannabinol, sesame oil and biogenic amines: a preliminary report.
    Anton AH; Serrano A; Beyer RD; Lavappa KS
    Life Sci; 1974 May; 14(9):1741-6. PubMed ID: 4407739
    [No Abstract]   [Full Text] [Related]  

  • 20. Delta 9-tetrahydrocannabinol-induced alterations in limbic system glucose use in the rat.
    Brett R; MacKenzie F; Pratt J
    Neuroreport; 2001 Nov; 12(16):3573-7. PubMed ID: 11733714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.